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Abstract
Objectives: Although several environmental factors contribute to the etiology of late-life 
depressive symptoms, the role of ambient air pollution has been understudied. Experimental data 
support the neurotoxicity of airborne particulate matter with aerodynamic diameter of ≤ 2.5 μm 
(PM2.5), but it remains unclear whether long-term exposure is associated with late-life depressive 
symptoms. Our secondary aim was to explore whether the observed associations between exposure 
and depressive symptoms are explained by dementia risk.
Design, Setting, and Participants: Prospective community-dwelling cohort study from the 
Women’s Health Initiative Study of Cognitive Aging (1999–2010). Our analyses included 1,989 
older women (baseline age 73.3+3.75) with no prior depression or cognitive impairment.
Measurements: Participants completed annual assessments of depressive symptoms (15-item 
Geriatric Depression Scale). Average ambient PM2.5 exposure at the residential location was 
estimated by spatiotemporal modeling for the three-years preceding each neuropsychological 
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assessment. Participants underwent separate annual examinations for incident dementia defined by 
DSM-IV. Latent-class mixture models examined the association between PM2.5 and identified 
trajectories of symptoms.
Results: Six trajectories of depressive symptoms were identified. Across all women, PM2.5 
exposure was positively associated with depressive symptoms. The effect was especially strong in 
two clusters with sustained depressive symptoms (n=625 sustained-mild [31%]; n=125 sustained-
moderate; [6%]). Among those with sustained-moderate symptoms, the estimated adverse effect of 
PM2.5 exposure was greater than that of hypertension. Among women without dementia, 
associations were modestly attenuated.
Conclusions: Long-term exposure to ambient fine particles was associated with increased 
depressive symptoms among older women without prior depression or cognitive impairment.
Keywords
depressive symptoms; air pollution; epidemiology
Objective
Late-life depressive symptoms are common, disproportionally affect women (1), impair 
functioning and quality of life, and are a significant burden to public health (2), even when 
the total number of symptoms does not meet criteria for a clinical diagnosis (3). Etiologies 
of depressive symptoms that emerge in later life (after age 65) likely differ from the causes 
of mood symptoms with an earlier-life onset (4). Both clinical and epidemiologic data has 
shown that late-life depression is heterogenous in nature with multiple contributing factors 
including cerebrovascular disease (5), neurodegeneration, and medical comorbidities (6). 
While twin studies suggest that late-life depressive symptoms are heritable, environmental 
factors explain the majority of the variance (7). However, there has been limited longitudinal 
environmental epidemiologic research on depressive symptoms that considers the distinct 
trajectories of symptoms over time (8). Previous research largely focused on psychosocial 
factors and depressive symptoms (9), and the potential role of physical environments has 
been understudied.
There is increasing evidence that ambient air pollutants, especially fine particulate matter 
(PM2.5; aerodynamic diameter <2.5 μm), is associated with accelerated brain aging (10). For 
instance, late-life exposure to PM2.5 was associated with increased risk for dementia among 
older women in the US (11). Experimental models also demonstrate airborne particle 
exposure can accelerate the neurodegenerative processes (11–13). Although 
neurotoxicological studies have shown depressive-like behaviors in mice exposed to 
particles (14–16), convincing epidemiologic data are lacking. Few longitudinal studies have 
examined the long-term associations between PM2.5, depressive symptomatology and onset 
of depression, but findings were mixed (17–20). These studies suffered from major 
methodological weaknesses, including short follow-up time with only two repeated 
assessments (18,19), ignoring the heterogeneity in trajectories of depressive symptoms over 
time (18–20), utilizing medical records for the ascertainment of depression (17,20), and 
inadequate control of potential confounders (20). Past research has not excluded individuals 
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with a past history of depression so results may be biased due to potential confounding by 
other environmental exposure that have affected emotional health before the study baseline 
(19). Lastly, no published data has offered insights into the possible mechanistic pathways 
underlying the hypothesized associations.
Here, we conducted a longitudinal study to examine the association between air pollution 
and late-life depressive symptoms assessed annually (1999–2010) in a geographically-
diverse sample of community-dwelling older women without prior depression or cognitive 
impairment. Our primary aim was to investigate whether long-term exposure to PM2.5 in 
late-life affected the trajectories of depressive symptoms, while rigorously controlling for 
potential confounders. We hypothesized that exposure to PM2.5 will be positively associated 
with depressive symptoms in later life. Our secondary aim was to explore whether any 
associations between exposure and depressive symptoms may be explained by dementia 
risk, regional brain volumes, or magnetic resonance imaging (MRI) measures of 
cerebrovascular damage that are known to be associated with PM2.5 exposure and/or 
depressive symptoms in late life. We hypothesized that dementia risk, regional brain 
volumes, and MRI measures of cerebrovascular damage would partially explain any putative 
associations between PM2.5 exposure and late life depressive symptoms.
Methods
Study Population
This study included 1,989 community-dwelling older women (aged 73.3±3.8 years old at 
baseline) without prior depression or dementia who were enrolled in the Women’s Health 
Initiative Study of Cognitive Aging (WHISCA; n=2,304) (21), an ancillary study to the 
Women’s Health Initiative Memory Study (WHIMS) (22) which was an ancillary study to 
the Women’s Health Initiative Hormone Clinical Trial (23). These women completed annual 
(1999–2010) neuropsychological assessments, beginning on average three years after 
randomization in the Women’s Health Initiative hormone therapy trial. Excluded from the 
present study (see Figure 1) were women who reported a history of depression (n=221) 
before the initial WHISCA assessment and those with missing data on covariates of interest 
(n=92). Our analyses also included a subsample of WHISCA participants (n=947) who 
underwent a single brain MRI scan in the Women’s Health Initiative Memory Study-MRI 
(WHIMS-MRI) study between 2005–2006 (24). A detailed description of these original 
study cohorts was given in the Supplemental Methods. This study was approved by the 
institutional review boards at all institutions and all participants provided written informed 
consent.
Assessment of depressive symptoms
Depressive symptoms were assessed at WHISCA baseline and at each annual follow-up (up 
to 9 assessments) using the 15-item Geriatric Depression Scale (GDS-15) (25,26). WHISCA 
participants were coded as having a past history of depression if they stated yes to both of 
the depression questions from the National Institute of Mental Health Diagnostic Interview 
Schedule at the WHIMS baseline that took place between 1996–1999 (27).
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Assessment of ambient PM2.5
Detailed procedures for PM2.5 estimation have previously been reported (11, 28). Briefly, 
residential addresses were collected at WHI enrollment and at each annual assessment. 
Standardized protocols (29) were followed for geocoding residential addresses. Daily 
ambient concentration of PM2.5 at each residential location was estimated using the 
Bayesian Maximum Entropy-based spatiotemporal modeling method. This approach 
integrates nationwide monitoring data from the U.S. Environmental Protection Agency Air 
Quality System and the output of chemical transport models. Estimates of daily PM2.5 
exposures were statistically cross-validated (average Pearson’s R2 = .70). The resulting 
exposure estimates were then aggregated in creating time-dependent estimates of average 
PM2.5 exposure for the 3-years preceding each respective WHISCA assessment.
Classification of dementia
Incident cases of all-cause dementia were defined using Diagnostic and Statistical Manual of 
Mental Disorders, Fourth edition (DSM-4) (30) criteria. Classification of dementia was 
based on annual screening of cognitive function, neuropsychological and functional 
assessment, and collection of clinical data to rule out possible reversible causes of cognitive 
declines through continued WHIMS participation. Annual screenings of all WHIMS 
participants were completed through administration of the Modified Mini Mental Status 
(3MS)(31) examination. Beginning in 2008, and continuing to the present, annual cognitive 
assessment were conducted by telephone using a validated battery (32,33) via participation 
in the WHIMS-Epidemiology of Cognitive Health Outcomes study.
Structural MRI assessment
Participants underwent one structural MRI, collected by standardized protocols (24). 
Measures of brain volume (in cm3) included: total volume of normal-appearing white matter, 
prefrontal grey matter volume, hippocampal volume and total volumes of small-vessel-
ischemic-diseases. These variables were selected because previous studies suggest they were 
brain areas affected by PM2.5 exposure (34,35) or associated with late-life depression (5,36).
Assessment of covariates
A structured questionnaire was administered at the WHIMS baseline (between 1996–1999) 
to gather information on the time-independent covariates of demographics (age, race/
ethnicity), geographic region of residence (Northeast, South, Midwest, and West), 
socioeconomic status (education; family income; employment status), lifestyle factors 
(smoking; alcohol use; physical activities), clinical characteristics (postmenopausal hormone 
treatment, history of CVD (including previous coronary heart, stroke, or transient ischemic 
attack), hypertension (defined as elevated blood pressure or use of antihypertensive 
medication), and diabetes mellitus (defined as physician diagnosis plus oral medications, or 
insulin therapy). Good reliability and validity of the self-reported medical histories and the 
physical measures have been previously documented (37). Estimates were adjusted for 
global cognitive ability by including the 3MS (38) as a covariate in all analyses. The 3MS is 
a reliable and valid measure of global cognitive ability and was administered at the WHIMS 
baseline assessment.
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Latent class mixed models (LCMM) (39) with a latent process transformation applied to the 
continuous score of the GDS-15 (to account for non-Gaussian nature of depressive 
symptoms; see Supplemental Figure 1 for graph of the transformation function) were fit to 
identify groups of women who had similar trajectories of depressive symptoms over time 
(See a more detailed description in the Supplemental Methods). A higher score represented 
more depressive symptoms and the function linking continuous GDS-15 scores to the 
transformed score is provided in Supplemental figure 1. Years since WHISCA baseline was 
utilized as the timescale. We started with a base LCMM that included a quadratic function of 
time (years since WHISCA baseline squared) and attrition (time-dependent covariate if the 
participant dropped out at the subsequent visit; 0=no, 1=yes) as fixed effects to identify the 
number of classes. We first fit a one-class model and sequentially increased the number of 
estimated latent classes. The decision of the total number of latent classes to be retained was 
made by a combination of overall model fit as evidenced by the Bayesian Information 
Criterion (BIC), the interpretability of the latent classes, the clinical meaningfulness of the 
class, and how well the latent classes differentiated between participants. See the 
Supplemental methods for a more detailed description of the approach to decide the number 
of significant latent classes to retain.
A second series of LCMM analyses were fit to examine the associations between PM2.5 
exposure and depressive symptoms. While extracting the same number of latent classes as 
identified from the base LCMM, we first examined whether PM2.5 exposure had a global 
effect on the transformed GDS-15 scores, assuming a common exposure effect across all 
identified trajectories after adjusting for demographic features, socioeconomic status, 
lifestyle factors, and clinical characteristics. In the subsequent LCMM adjusting for the 
same set of covariates, the putative association between PM2.5 and depressive symptoms was 
then re-examined as a class-specific effect, which allowed the association with PM2.5 to vary 
in magnitude by latent class.
Secondary analyses
To explore whether dementia risk statistically explained the observed PM2.5 exposure 
effects, the first set of secondary analyses were conducted only using the data collected in 
the subsample (n=1,811) who had not developed dementia by December 2015, as 
determined by standardized protocols and central adjudication (11). Participants were 
assigned a priori to latent class membership based on the same class membership already 
determined in the full-sample LCMM with PM2.5 included. We examined the global and 
class-specific PM2.5 associations and compared the magnitude of these effect estimates to 
the results from the full model.
Exploratory analyses were further conducted in the WHISCA participants with brain MRI 
data (n=947), to examine whether MRI estimates of structural brain volumes statistically 
explained the observed association between PM2.5 and depressive symptoms. We examined 
the global PM2.5 effect in this subsample, as well as the class-specific exposure effect, which 
was only tested among women belonging to classes with significant associations as 
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identified from the primary analyses. Subsequent LCMMs were constructed separately by 
adding respective MRI variables into the model.
Sensitivity analyses
Lastly, two additional sets of sensitivity analyses were conducted: 1) using an alternative 
approach to defining prior depression; and 2) further adjusting for neighborhood 
socioeconomic characteristics (40) (detailed in the Supplemental methods). All models were 
fit with the LCMM program (39) in R version 3.5.0 (41).
Results
Participant characteristics, PM2.5 exposure distribution and trajectories of depressive 
symptoms
The majority of these older women (N=1,989; aged 73.3±3.8 years) were Caucasian (91%) 
and had more than a high-school education (74%). Table 1 compares the distribution of 3-
year average PM2.5 exposure estimates by population characteristics. Participants exposed to 
higher levels of PM2.5 were more likely to self-identify as African-American or Hispanic, 
reside in the Midwest or West, report higher household incomes (≥$75,000) or prior 
histories of cardiovascular disease.
Base LCMM identified six trajectories of depressive symptoms (Supplemental Table 1), 
including: 779 with minimum GDS-15 scores throughout the study period (39% minimal), 
228 with depressive symptoms emerging early in follow-up (11% early-emerging),159 with 
depressive symptoms increasing during the latter part of the follow-up period (8% late-
emerging), 644 with mildly elevated GDS-15 scores sustained during the follow-up (32% 
sustained-mild), 70 starting with elevated GDS-15 scores that decreased over the follow-up 
(4% decreasing), and 109 with sustained-moderate GDS-15 scores (5% sustained-moderate). 
Figure 2 (panel A) depicts the estimated mean GDS-15 scores over time with 95% 
confidence intervals for each latent class. A reference line was included on this graph at a 
score of 5 or higher to aid in clinical interpretation of these classes as this score is a 
commonly used cutoff for clinically significant depressive symptoms. Supplemental Figure 
2 presents the estimated mean GDS-15 score with individual scores over time. The odds of 
correct classification were over 5 for all six latent classes, and, with the exception of the 
late-emerging class (PP = .65), had average posterior probabilities over .70. Table 2 presents 
the study variables by the six identified latent classes. Clinically meaningful differences 
between classes were present as women with sustained-mild or sustained-moderate 
symptoms tended to be in worse physical health with higher proportions of hypertension, 
cardiovascular disease, and diabetes at baseline, less frequently engaged in moderate or 
strenuous physical activity, and were more likely to drink alcohol compared to women in 
other trajectories.
Associations between PM2.5 exposure and GDS trajectories
Results from the multicovariate-adjusted LCMM analyses are presented in Table 3. In the 
LCMM including PM2.5 with adjustment for multiple covariates, a six-class solution still 
provided the best fit to the data. In models estimating the global PM2.5 effect constrained 
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across the six identified classes, we found significantly more depressive symptoms (β=.043; 
p = .039) among older women living in locations with elevated PM2.5 (~ by 3.45 μg/m3). 
When examining class-specific effects (all PM2.5 estimates presented in the left panel of 
Table 3), higher PM2.5 exposure was positively associated with depressive symptoms only in 
women who had sustained-mild (β=.096; p =.023) and sustained-moderate symptoms (β=.
171.; p =.024), but the strengths of associations within these two classes were 2–4 times 
greater than the estimated global main effect. Figure 2 (panel B) provides the estimated 
average GDS-15 score among women in the trajectories of sustained-mild or -moderate 
depressive symptoms, separately by high (upper quartile), median, and low (lower quartile) 
PM2.5 levels as compared with the corresponding effect estimates of selected covariates 
(estimated at the mean level of PM2.5). Estimated depressive symptoms for women exposed 
to the median PM2.5 and for those who had diabetes and hypertension at baseline were also 
plotted to put the PM2.5 effect into the clinical context for comparison. Among those with 
sustained-moderate symptoms, the magnitude of the adverse PM2.5 effect estimate (per 1-
interquarile exposure range) was greater than that of hypertension.
Secondary analyses
Long-term PM2.5 exposure was associated with increased depressive symptoms in the 
dementia-free sample (n = 1,811). Compared to the corresponding LCMM results in the full 
sample, the estimates of class-specific PM2.5 effects were similar among WHISCA 
participants without dementia (right panel of Table 3), although the strength of association 
was slightly diminished and more precise in the subgroup with sustained-moderate 
depressive symptoms. The global effect estimate was attenuated, but remained statistically 
significant (β=.038; p = .006). Interestingly, the class-specific LCMM also revealed the 
statistically significant association with PM2.5 (β=.175; p <.001) among WHISCA 
participants who had late-emerging depressive symptoms but did not have dementia.
Exploratory analyses
Among the subsample of WHISCA participants with brain MRI data (n=974), both the 
global and class-specific PM2.5 exposure effects were statistically significant (Supplemental 
Table 2; Model-1). These associations were largely unchanged and remained statistically 
significant after we further accounted for various MRI-measured regional brain volumes 
(Supplemental Table 2; Model-2 to Model-5).
Sensitivity Analyses
In the sensitivity analyses where no prior depression was defined by endorsing clinically 
significant symptoms, we observed a similar pattern of estimated latent classes 
(Supplemental Table 3). The same pattern of results emerged in the LCMM that further 
adjusted for neighborhood socioeconomic characteristics (Supplemental Table 4).
Conclusions
In this longitudinal study conducted on a geographically-diverse cohort of older women with 
thorough neuropsychological assessments and no prior depression, we used latent-class 
mixed models to identify six significant clusters of women who exhibited similar trajectories 
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of depressive symptoms assessed annually up to 11-years. Long-term exposure to ambient 
PM2.5 estimated at the residential locations was associated with increased depressive 
symptoms, especially among the two clusters of older women who experienced sustained-
mild and moderate depressive symptoms. This association was robust after adjusting for 
multiple potential confounders and other risk factors for late-life depression. Our analyses 
also showed that dementia risk did not fully explain this association. In a subsample of 
women who underwent structural brain MRI imaging, differences in their volumetric 
measures of normal-appearing white matter, prefrontal cortex, hippocampus, and small-
vessel-ischemic-disease could not explain the observed increase in depressive symptoms 
associated with long-term PM2.5 exposure. The neuropathological processes underlying the 
putative neurotoxic effect of PM2.5 exposure in late life remains elusive, but are damage. 
likely independent of cerebrovascular damage.
Our study addresses the limitations of previous research on air pollution and emotional 
health (see Supplemental Table 5) in several ways. Null associations between long-term 
PM2.5 exposure and depressive symptoms of community-dwelling populations were reported 
in two longitudinal studies (18,19), one conducted in Boston (aged ≥65 years) and the other 
across the U.S. (aged 57–85 years). Neither study excluded individuals with a prior history 
of depression. This restriction not only ensures the study outcome most relevant to late-life 
depressive symptoms, but also helps reduce the potential confounding by other 
environmental exposures (including early/mid-life PM2.5) and genetic associations 
presumably affecting emotional health before the baseline. With the depressed symptoms 
only assessed twice, investigators were unable to characterize the longitudinal trajectories, 
thus missing the opportunity to examine the potential heterogeneity of exposure effects. Kim 
et al. (42) reported that long-term PM2.5 exposure increased the risk of major depression 
amongst the general population of Seoul, Republic of Korea (15–79 years old). However, 
participants were followed for two years, and the difference in early-life and late-life 
depression was disregarded. Only aggregated measures of air pollution exposure were used 
in their analyses that did not adequately account for confounding by socioeconomic status. 
Also, their ascertainment for depressive disorders was based on diagnostic codes in medical 
claims data, an approach known to suffer from outcome misclassification with only modest 
accuracy (43) and low sensitivity (44). Kioumourtzoglou et al. (17) carefully excluded those 
with reported prior depression from an US-nationwide cohort of older women (aged 
66.6±7.6). Their observed association, however, was sensitive to different outcome 
definitions and the inclusion of subjects with comorbid conditions presumably associated 
with late-life depressive symptoms. Although clinical entities of depression often represent 
arbitrarily defined categories with more extreme manifestations of the continuum of 
depressive symptoms, the above-mentioned methodological limitations point to the need for 
future studies with high-quality longitudinal data on outcome (including diagnostic 
interviews) and comorbidities to examine the association between PM2.5 and depressive 
disorders.
Our study adds novel data to the emerging field of environmental neurosciences of air 
pollution and brain aging. Previous studies have shown long-term PM2.5 exposure may 
increase risk of dementia (10), including our report based on WHIMS data (11). Empirical 
data from WHISCA also showed that GDS-15 trajectories predicted the risk for dementia 
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(data not shown) (45). Taken together, all these data point to two interesting possibilities. 
First, if late-life depressive symptoms represent a prodromal neuropsychiatric manifestation 
of dementia (46), findings of the present study suggest that PM2.5 may perturb the common 
neuropathological processes leading to the trajectories with sustained depressive symptoms 
and an increased risk for dementia. Second, it is also possible both depressive symptoms and 
dementia have shared risk factors, and late-life exposure to PM2.5 may represent an example 
of such common environmental causes acting upon overlapping or distinctive pathways to 
compromise emotion regulation abilities.
No previous epidemiologic data were available to help elucidate the neural basis of 
increased depressive symptoms associated with air pollution exposure. In the informative 
subsample of older women participating in both WHISCA and WHIMS-MRI, we found 
both the global PM2.5 effect and the class-specific exposure effect (especially among those 
with sustained-moderate symptoms) remained statistically significant after we further 
accounted for various MRI-measured regional brain volumes (e.g., prefrontal cortex, 
normally-appearing white matter) with negative associations with PM2.5 exposure. These 
results underscore the need for future studies to investigate other brain regions and neural 
networks vulnerable to the PM2.5 neurotoxicity that may predispose older people to 
increased depressive symptoms in late life.
The findings in this study have potential important policy and clinical implications. These 
findings emphasize the importance of enforcing environmental regulations (e.g., the Clean 
Air Act) and initiatives for other public policies to minimize the adverse impact of ambient 
air pollutants on older adults. Clinicians might consider air pollution as a possible 
contributing factor to their patients’ depressive symptoms and can provide relevant 
psychoeducation to their patients.
We recognize several limitations of our study. First, although the PM2.5 spatiotemporal 
model was statistically cross-validated (average Pearson’s R2=0.70) (28), the resulting 
exposure estimates were still subject to measurement errors. However, such estimation errors 
are likely non-differential and tend to attenuate the observed associations. Second, we only 
studied PM2.5 exposure as regional air pollutants, with no data on its chemical 
constituencies, emission sources, or possible interactions with other pollutant mixtures. 
Third, structural MRI data was only available for a subsample of women in our study and 
was cross-sectional. Fourth, although the application of the latent process transformation to 
GDS-15 scores was necessary statistically, the clinical interpretation of our findings may not 
be straightforward. However, given the informative comparison made between the adverse 
PM2.5 effect and several clinical comorbidities (Figure 2), we advocate for more use of 
LCMM with latent process score for studying clinically-relevant questions on late-life 
depressive symptoms in future research. Fifth, our analyses of brain MRI data were largely 
based on region-of-interest with only volumetric measures of global regions – an approach 
that may not have the sufficient sensitivity and specificity to identify areas vulnerable to 
PM2.5 neurotoxicity or critical to emotion regulation. We only analyzed data from a single 
structural MRI and thus limits our ability to make inferences about the extent to which 
PM2.5 exposure is associated with change in structural MRI variables and depressive 
symptoms over time. Future research needs to utilize repeated MRI measures to examine 
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whether there are PM2.5 associated changes in brain volumes based on depressive symptom 
trajectories. Lastly, future studies should consider high-dimensional analyses, including the 
use of machine learning (47) that may offer a better approach to understanding the likely 
complex brain structure and neural networks linking PM2.5 exposure with depressive 
symptoms in late life.
This study had several major strengths. First, women were followed over a long period up to 
11 years with a maximum of nine assessments of their depressive symptoms. Second, we 
employed the sophisticated LCMM modeling approach, which allowed us to identify the 
trajectories of depressive symptoms as the basis for examining the heterogeneity of PM2.5 
exposure effects. Third, we had access to well-validated data on dementia and MRI-based 
measures of regional brain volumes and cerebrovascular damage, which enabled the first 
step to explore the potential contributors to the neuropathological processes linking late-life 
exposure to PM2.5 with GDS-15 trajectories. Lastly, the rich, comprehensive covariate data 
from the WHIMS cohort offered a unique population context for optimal study design that 
excludes individuals with prior depression and rigorously assess and adjust for potential 
confounding.
In conclusion, among older women with no prior depression or dementia, long-term 
exposure to ambient fine particles is a novel environmental risk factor for sustained 
depressive symptoms, independent of other known risk factors for late-life depression. 
Future studies need to better understand the biological underpinnings of this association.
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What is the primary question addressed by this study?
Is late-life exposure to PM2.5 (particulate matter with aerodynamic diameters < 2.5 μm) 
associated with depressive symptoms in older women without prior depression or 
dementia and if so, how?
What is the main finding of this study?
In this 11-year longitudinal study (n= 1,989), residing in locations with higher ambient 
PM2.5 increased the annually-assessed depressive symptoms, especially among women 
with sustained mild or moderate symptoms. Dementia risk only partially explained this 
association, which was independent of MRI-measured brain volumes and small-vessel-
ischemic-disease.
What is the meaning of this study?
In older women, late-life PM2.5 exposure is a novel environmental risk factor of 
depressive symptoms, but the neurobiological mechanisms are unclear.
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Flowchart of study participants included in the analyses
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Graph of the estimated mean score of the 15-item Geriatric Depression Scale with 95% 
confidence intervals over time by latent class (panel A). The trajectories of depressive 
symptoms affected by exposure were depicted over time by high (upper quartile), mean, and 
low (lower quartile) PM2.5 exposure for women with sustained depressive symptoms (panel 
B). The reference trajectories of estimated average scores on 15-item Geriatric Depression 
Scale for women with hypertension, cardiovascular disease, or diabetes were plotted as 
reference groups with assumed exposures to median PM2.5 levels. A dotted reference line 
was added at the GDS-15 score of 5 in order to provide a benchmark for clinically 
significant depressive symptoms.
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Table 1.
Comparison of Estimated PM2.5Exposure by Baseline Population Characteristics (N=1,989).
Distribution of time-varying 3-year averagePM2.5
a
Mean ± SD
Population Characteristics N (25th percentile, median, 75th percentile) p
b
Overall 1,989 12.61 ± 2.58 (10.74, 12.03, 14.19)
Region <0.01
 Northeast 418 12.18 ± 1.33 (11.1, 12.1, 13.2)
 South 299 12.21 ± 1.77 (10.6, 11.8,14)
 Midwest 772 12.85 ± 2.43 (10.7, 12.3, 15.4)
 West 500 12.84 ± 3.69 (10.7, 11.8, 14.9)
Ethnicity <0.01
 African-American 115 15.23 ± 2.39 (13.8, 14.7, 16.6)
 Hispanic White 23 12.74 ± 2.45 (11.1, 11.9, 14.1)
 White (not Hispanic) 1802 12.41 ± 2.47 (10.7, 11.8, 13.9)
 Other or Missing 49 13.81 ± 3.41 (11.4, 12.9, 16.2)
Education 0.02
 Less than high school 89 12.48 ± 2.55 (10.9, 11.7, 14.1)
 High school 431 12.32 ± 2.24 (10.6, 11.7, 13.6)
 More than high school 1469 12.7 ± 2.67 (10.8, 12.1, 14.3)
Employment 0.43
 Currently working 383 12.49 ± 2.61 (10.7, 12, 14)
 Not working 190 12.79 ± 2.62 (10.8, 12.2, 14.7)
 Retired 1416 12.62 ± 2.56 (10.8, 12, 14.2)
Income (USD) <0.01
 < 9,999 422 12.34 ± 2.57 (10.6, 11.5, 14.1)
 10,000–34,999 625 12.58 ± 2.51 (10.7, 12.1, 14.1)
 35,000–49,999 430 12.6 ± 2.53 (10.7, 12, 14)
 50,000–74,999 277 12.82 ± 2.71 (11, 12.2, 14.2)
 75,000 or more 176 13.19 ± 2.75 (11, 12.5, 14.9)
 Don’t know 59 12.27 ± 2.3 (10.7, 11.9, 13.5)
Lifestyle
Smoking status 0.44
 Never smoked 1106 12.64 ± 2.61 (10.7, 12, 14.3)
 Past smoker 775 12.61 ± 2.51 (10.8, 12.1, 14)
 Current Smoker 108 12.31 ± 2.72 (10.5, 11.7, 14.1)
Alcohol use 0.07
 Non-drinker 246 12.99 ± 2.7 (10.7, 12.5, 14.8)
 Past drinker 347 12.57 ± 2.54 (10.7, 12, 14.4)
 Less than 1 drink per day 1148 12.52 ± 2.55 (10.7, 12, 13.9)
 More than 1 drink per day 248 12.69 ± 2.61 (10.9, 12, 14.2)
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Distribution of time-varying 3-year averagePM2.5
a
Mean ± SD
Population Characteristics N (25th percentile, median, 75th percentile) p
b
Moderate or strenuous physical activities ≥ 20 minutes 0.42
 No activity 1128 12.65 ± 2.64 (10.7, 12.1, 14.3)
 Some activity 107 12.73 ± 2.35 (10.8, 12.2, 14.6)
 2–4 episodes/wk 413 12.64 ± 2.48 (10.8, 12, 14.2)
 ≥4 episodes/week 341 12.4 ± 2.56 (10.6, 11.8, 13.7)
Physical Health
Hypertension 0.24
 No 1261 12.56 ± 2.57 (10.7, 12, 14.2)
 Yes 728 12.7 ± 2.6 (10.8, 12.1, 14.3)
High Cholesterol 0.14
 No 1641 12.57 ± 2.57 (10.7, 12, 14.2)
 Yes 348 12.8 ± 2.6 (10.8, 12.2, 14.3)
Diabetes 0.84
 No 1890 12.61 ± 2.59 (10.7, 12, 14.2)
 Yes 99 12.56 ± 2.34 (10.9, 12.1, 13.8)
Cardiovascular disease 0.03
 No 1680 12.56 ± 2.56 (10.7, 12, 14.1)
 Yes 309 12.91 ± 2.65 (10.9, 12.4, 14.8)
Hormone treatment ever 0.86
 No 1083 12.6 ± 2.49 (10.7, 12.1, 14.1)
 Yes 906 12.62 ± 2.68 (10.8, 12, 14.3)
a
PM2.5 represents the distribution of the individual-level summary of all time-varying 3-year exposures aggregated from the daily exposure levels 
estimated at each residential location using the spatiotemporal model.
b
p values estimated from ANOVA F-tests or t-tests
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Table 2.
Comparison of Baseline Population Characteristics by Latent Class
a
of Depressive Symptoms in the Women’s 
Health Initiative Study on Cognitive Aging (N = 1,989).
Resilient
Early 
emerging Late emerging Sustained-Mild Decreasing
Sustained-
Moderate
N = 779 N = 228 N = 159 N = 644 N = 70 N = 109
Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd)
















Age (years) 73.00 (3.56) 73.37 (3.82) 72.72 (3.45) 73.83 (4.02) 72.89 (3.61) 73.87 (3.71) <.01
GDS-15
d
.25 (.58) .09 (.3) 1.36 (1.43) 2.12 (1.57) 3.09 (2.25) 5.79 (2.5) <.01
Region .08
 Northeast 39% (163) 10% (43) 8% (33) 34% (144) 3% (12) 6% (23)
 South 37% (110) 12% (37) 10% (31) 33% (100) 3% (9) 4% (12)
 Midwest 40% (310) 14% (109) 8% (59) 29% (220) 4% (30) 6% (44)
 West 39% (196) 8% (39) 7% (36) 36% (180) 4% (19) 6% (30)
Ethnicity <.01
 African-American 34% (39) 10% (11) 6% (7) 36% (41) 3% (3) 12% (14)
 Hispanic White 17% (4) 17% (4) 4% (1) 35% (8) 4% (1) 22% (5)
 White (not Hispanic) 40% (713) 12% (212) 8% (150) 32% (577) 4% (64) 4% (86)
 Other or Missing 47% (23) 2% (1) 1% (1) 37% (18) 4% (2) 8% (4)
Education <.01
 Less than high school 24% (21) 16% (14) 1% (1) 45% (40) 3% (3) 11 % (10)
 High school 38% (163) 11% (46) 9% (38) 32% (137) 4% (16) 7% (31)
 More than high school 41% (595) 11% (168) 8% (120) 32% (467) 3% (51) 5% (68)
Employment .01
 Currently working 39% (148) 10% (37) 12% (47) 32% (122) 3% (11) 5% (18)
 Not working 40% (76) 10% (18) 2% (4) 40% (76) 4% (7) 5% (9)
 Retired 39% (555) 12% (173) 7% (108) 32% (446) 4% (52) 6% (82)
Annual income
(dollars) <.01
 < 9,999 31% (129) 12% (50) 8% (32) 39% (165) 2% (9) 9% (37)
 10,000–34,999 38% (235) 10% (65) 8% (52) 36% (224) 3% (18) 5% (31)
 35,000–49,999 43% (185) 13% (58) 8% (34) 26% (110) 4% (18) 6% (25)
 50,000–74,999 48% (132) 9% (26) 10% (28) 24% (66) 5% (13) 4% (12)
 75,000 or more 45% (79) 14% (25) 5% (9) 31% (55) 4% (7) 1% (1)
 Don’t know 32% (19) 7% (4) 7% (4) 41% (24) 8% (5) 5% (3)
Lifestyle
Smoking status 0.55
 Never smoked 40% (447) 12% (130) 8% (89) 30% (337) 3% (38) 6% (65)
 Past smoker 38% (292) 12% (91) 8% (62) 34% (266) 3% (28) 5% (36)
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Resilient
Early 
emerging Late emerging Sustained-Mild Decreasing
Sustained-
Moderate
N = 779 N = 228 N = 159 N = 644 N = 70 N = 109
Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd)
















 Current Smoker 37% (40) 6% (7) 7% (8) 38% (41) 4% (4) 7% (8)
Alcohol use 0.03
 Non-drinker 42% (103) 14% (34) 8% (20) 29% (71) 4% (11) 3% (7)
 Past drinker 32% (112) 9% (32) 10% (33) 39% (134) 3% (10) 7% (26)
 Less than 1 drink / day 39% (449) 12% (137) 8% (89) 32% (364) 4% (42) 6% (67)
 More than 1 drink / day 46% (115) 10% (25) 7% (17) 30% (75) 3% (7) 4% (9)
Moderate or strenuous physical activities ≥ 20 minutes <.01
 No activity 35% (394) 10% (113) 8% (93) 37% (415) 3% (35) 7% (78)
 Some activity 37% (40) 17% (18) 12% (13) 25% (27) 3% (3) 6% (6)
 2–4 episodes/wk 44% (180) 13% (53) 4% (18) 30% (125) 5% (19) 4% (18)
 ≥episodes/week 48% (165) 13% (44) 10% (35) 23% (77) 4% (13) 2% (7)
Physical Health
Hypertension <.01
 No 42% (532) 11% (143) 8% (98) 29% (368) 4% (52) 5% (68)
 Yes 34% (247) 12% (85) 8% (61) 38% (276) 2% (18) 6% (41)
High Cholesterol .53
 No 40% (657) 11% (187) 8% (130) 32% (526) 3% (54) 5% (87)
 Yes 35% (122) 12% (41) 8% (29) 34% (118) 5% (16) 6% (22)
Diabetes <.01
 No 40% (753) 12% (224) 8% (151) 32% (599) 4% (69) 5% (94)
 Yes 26% (26) 4% (4) 8% (8) 45% (45) 1% (1) 15% (15)
Cardiovascular disease .01
 No 41% (685) 11% (187) 8% (133) 31% (527) 4% (62) 5% (86)
 Yes 30% (94) 13% (41) 8% (26) 38% (117) 3% (8) 7% (23)
Hormone treatment
ever .30
 No 41% (447) 11% (123) 8% (89) 30% (329) 4% (38) 5% (57)
 Yes 37% (332) 12% (105) 8% (70) 35% (315) 4% (32) 6% (52)
Baseline exposure
 PM2.5 (3-year average) 12.78 (2.4) 12.83 (2.4) 12.64 (2.16) 12.66 (2.46) 12.56 (2.38) 13.14 (2.52) .42
a
Group membership estimated from the latent class model that includes the initial level of depressive symptoms with both fixed effects and random 
intercept, linear and quadratic change of follow-up time, initial WHISCA age, and attrition (yes/no if participant dropped out at the subsequent 
assessment time) to account for heterogeneity in the longitudinal profiles of depressive symptoms.
b
Percentage reported above represent row percentages.
c
p values calculated from chi-square or fisher exact tests for categorical variables, from ANOVA F-tests for continuous variables
d
GDS-15 = Geriatric Depression Scale-15
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Table 3.
Effect of Time-Varying 3-Year Average PM2.5 Exposure on Depressive Symptoms Measured by the 15-Item 
Geriatric Depression Scale in the Women’s Health Initiative Study of Cognitive Aging
a
PM2.5 Effect Estimate
Full sample Dementia-free sample
N = 1,989 N=1,811
βb SEc p βb SEc p
Model 1:Global main effect
Exposure effect estimate common to all 
classes .043 .021 .039
Exposure effect estimate common to all 
classes .038 .014 .006
Model 2: Class-specific exposure effect
Minimal (n=802) .021 .026 .426 Minimal (n=737) .014 .020 .489
Early-emerging (n=214) −.005 .124 .968 Early-emerging (n=199) −.008 .042 .855
Late-emerging (n=158) .168 .106 .113 Late-emerging (n=141) .175 .050 <.001
Sustained-mild (n=626) .096 .042 .023 Sustained-mild (n=568) .086 .026 <.001
Decreasing (n=67) −.141 .104 .176 Decreasing (n=62) −.078 .061 .201
Sustained-moderate (n=122) .171 .076 .024 Sustained-moderate (n=104) .151 .058 .009
a
All models adjust for age at WHISCA baseline, race/ethnicity, attrition, geographic region of residence, education, household income, 
employment status, baseline global cognitive ability, lifestyle factors (smoking, alcohol use, physical activities) and clinical characteristics (use of 
hormone treatment; hypercholest erolemia, hypertension, diabetes, and history of cardiovascular disease).
b
β = the average increase in transformed 15-item Geriatric Depression Scale score per increase of one interquartile range (3.45 μg/m3) of time-
varying 3-year average exposure to PM2.5
c
SE = the standard error of the estimated effect of PM2.5 on 15-item Geriatric Depression Scale.
Bolded estimates denote p < .05
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